| 1 | [SID24269529] | Unspecified | | | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists [AID485344, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 24269529 | | CID | 15989139 | | Outcome | Unspecified | | BioAssay | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists | | AID | 485344 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 2 | [SID24269529] | Unspecified | | | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists [AID485344, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 24269529 | | CID | 15989139 | | Outcome | Unspecified | | BioAssay | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists | | AID | 485344 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 3 | [SID24269529] | Unspecified | | | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists [AID485344, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 24269529 | | CID | 15989139 | | Outcome | Unspecified | | BioAssay | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists | | AID | 485344 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 4 | [SID24269529] | Unspecified | | | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists [AID485344, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 24269529 | | CID | 15989139 | | Outcome | Unspecified | | BioAssay | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists | | AID | 485344 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 5 | [SID24269529] | Unspecified | | | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists [AID485344, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 24269529 | | CID | 15989139 | | Outcome | Unspecified | | BioAssay | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists | | AID | 485344 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 6 | [SID24269529] | Inactive | | | HTS Assay for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Primary Screen for Potentiators [AID485347, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 24269529 | | CID | 15989139 | | Outcome | Inactive | | BioAssay | HTS Assay for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Primary Screen for Potentiators | | AID | 485347 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 7 | [SID24269529] | Inactive | | | HTS Assay for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Primary Screen for Potentiators [AID485347, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 24269529 | | CID | 15989139 | | Outcome | Inactive | | BioAssay | HTS Assay for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Primary Screen for Potentiators | | AID | 485347 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 8 | [SID24269529] | Inactive | | | HTS Assay for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Primary Screen for Potentiators [AID485347, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 24269529 | | CID | 15989139 | | Outcome | Inactive | | BioAssay | HTS Assay for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Primary Screen for Potentiators | | AID | 485347 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 9 | [SID24269529] | Inactive | | | HTS Assay for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Primary Screen for Potentiators [AID485347, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 24269529 | | CID | 15989139 | | Outcome | Inactive | | BioAssay | HTS Assay for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Primary Screen for Potentiators | | AID | 485347 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 10 | [SID24269529] | Inactive | | | HTS Assay for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Primary Screen for Potentiators [AID485347, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 24269529 | | CID | 15989139 | | Outcome | Inactive | | BioAssay | HTS Assay for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Primary Screen for Potentiators | | AID | 485347 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 11 | [SID24269529] | Inactive | | | HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists [AID485358, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 24269529 | | CID | 15989139 | | Outcome | Inactive | | BioAssay | HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists | | AID | 485358 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 12 | [SID24269529] | Inactive | | | HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists [AID485358, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 24269529 | | CID | 15989139 | | Outcome | Inactive | | BioAssay | HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists | | AID | 485358 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 13 | [SID24269529] | Inactive | | | HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists [AID485358, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 24269529 | | CID | 15989139 | | Outcome | Inactive | | BioAssay | HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists | | AID | 485358 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 14 | [SID24269529] | Inactive | | | HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists [AID485358, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 24269529 | | CID | 15989139 | | Outcome | Inactive | | BioAssay | HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists | | AID | 485358 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 15 | [SID24269529] | Inactive | | | HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists [AID485358, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 24269529 | | CID | 15989139 | | Outcome | Inactive | | BioAssay | HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists | | AID | 485358 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 16 | [SID24269529] | Inactive | Potency | | qHTS for Small Molecule Inhibitors of the ERG Ets/DNA interaction [AID624246, Type: confirmatory] | ERG gene product [Homo sapiens] [gi:343478176] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 24269529 | | CID | 15989139 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Small Molecule Inhibitors of the ERG Ets/DNA interaction | | AID | 624246 | | BioAssay type | confirmatory | | Target | ERG gene product [Homo sapiens] [gi:343478176] | | PubMed | | | Data Table |  |
|
| 17 | [SID24269529] | Inactive | Potency | | qHTS for Small Molecule Inhibitors of the ERG Ets/DNA interaction [AID624246, Type: confirmatory] | ERG gene product [Homo sapiens] [gi:343478176] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 24269529 | | CID | 15989139 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Small Molecule Inhibitors of the ERG Ets/DNA interaction | | AID | 624246 | | BioAssay type | confirmatory | | Target | ERG gene product [Homo sapiens] [gi:343478176] | | PubMed | | | Data Table |  |
|
| 18 | [SID24269529] | Inactive | Potency | | qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). [AID588795, Type: confirmatory] | flap endonuclease 1 [Homo sapiens] [gi:4758356] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 24269529 | | CID | 15989139 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). | | AID | 588795 | | BioAssay type | confirmatory | | Target | flap endonuclease 1 [Homo sapiens] [gi:4758356] | | PubMed | | | Data Table |  |
|
| 19 | [SID24269529] | Inactive | Potency | | Acumen qHTS Assay for Inhibitors of the mTORC1 Signaling Pathway in MEF (Tsc2-/-, p53-/-) Cells: Sytravon [AID493208, Type: confirmatory] | MTOR gene product [Homo sapiens] [gi:4826730] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 24269529 | | CID | 15989139 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Acumen qHTS Assay for Inhibitors of the mTORC1 Signaling Pathway in MEF (Tsc2-/-, p53-/-) Cells: Sytravon | | AID | 493208 | | BioAssay type | confirmatory | | Target | MTOR gene product [Homo sapiens] [gi:4826730] | | PubMed | | | Data Table |  |
|
| 20 | [SID24269529] | Inactive | Potency | | Acumen qHTS Assay for Inhibitors of the mTORC1 Signaling Pathway in MEF (Tsc2-/-, p53-/-) Cells: Sytravon [AID493208, Type: confirmatory] | MTOR gene product [Homo sapiens] [gi:4826730] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 24269529 | | CID | 15989139 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Acumen qHTS Assay for Inhibitors of the mTORC1 Signaling Pathway in MEF (Tsc2-/-, p53-/-) Cells: Sytravon | | AID | 493208 | | BioAssay type | confirmatory | | Target | MTOR gene product [Homo sapiens] [gi:4826730] | | PubMed | | | Data Table |  |
|
| 21 | [SID24269529] | Inactive | Potency | | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen [AID2100, Type: confirmatory] | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 24269529 | | CID | 15989139 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen | | AID | 2100 | | BioAssay type | confirmatory | | Target | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] | | PubMed | | | Data Table |  |
|
| 22 | [SID24269529] | Inactive | Potency | | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen [AID2100, Type: confirmatory] | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 24269529 | | CID | 15989139 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen | | AID | 2100 | | BioAssay type | confirmatory | | Target | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] | | PubMed | | | Data Table |  |
|
| 23 | [SID24269529] | Inactive | Potency | | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen [AID2100, Type: confirmatory] | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 24269529 | | CID | 15989139 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen | | AID | 2100 | | BioAssay type | confirmatory | | Target | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] | | PubMed | | | Data Table |  |
|
| 24 | [SID24269529] | Inactive | Potency | | qHTS Assay for Inhibitors of GCN5L2 [AID504327, Type: confirmatory] | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 24269529 | | CID | 15989139 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of GCN5L2 | | AID | 504327 | | BioAssay type | confirmatory | | Target | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] | | PubMed | | | Data Table |  |
|
| 25 | [SID24269529] | Inactive | Potency | | qHTS Assay for Inhibitors of GCN5L2 [AID504327, Type: confirmatory] | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 24269529 | | CID | 15989139 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of GCN5L2 | | AID | 504327 | | BioAssay type | confirmatory | | Target | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] | | PubMed | | | Data Table |  |
|
| 26 | [SID24269529] | Inactive | Potency | | qHTS of GLP-1 Receptor Agonists [AID624172, Type: confirmatory] | glp-1 receptor [Homo sapiens] [gi:1724069] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 24269529 | | CID | 15989139 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of GLP-1 Receptor Agonists | | AID | 624172 | | BioAssay type | confirmatory | | Target | glp-1 receptor [Homo sapiens] [gi:1724069] | | PubMed | | | Data Table |  |
|
| 27 | [SID24269529] | Inactive | Potency | | qHTS of GLP-1 Receptor Agonists [AID624172, Type: confirmatory] | glp-1 receptor [Homo sapiens] [gi:1724069] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 24269529 | | CID | 15989139 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of GLP-1 Receptor Agonists | | AID | 624172 | | BioAssay type | confirmatory | | Target | glp-1 receptor [Homo sapiens] [gi:1724069] | | PubMed | | | Data Table |  |
|
| 28 | [SID24269529] | Inactive | Potency | | qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode) [AID624417, Type: confirmatory] | glp-1 receptor [Homo sapiens] [gi:1724069] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 24269529 | | CID | 15989139 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode) | | AID | 624417 | | BioAssay type | confirmatory | | Target | glp-1 receptor [Homo sapiens] [gi:1724069] | | PubMed | | | Data Table |  |
|
| 29 | [SID24269529] | Inactive | Potency | | qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode) [AID624417, Type: confirmatory] | glp-1 receptor [Homo sapiens] [gi:1724069] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 24269529 | | CID | 15989139 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode) | | AID | 624417 | | BioAssay type | confirmatory | | Target | glp-1 receptor [Homo sapiens] [gi:1724069] | | PubMed | | | Data Table |  |
|
| 30 | [SID24269529] | Inactive | Potency | | qHTS for Inhibitors of Glutaminase (GLS) [AID624170, Type: confirmatory] | GLS protein [Homo sapiens] [gi:71051501] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 24269529 | | CID | 15989139 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Glutaminase (GLS) | | AID | 624170 | | BioAssay type | confirmatory | | Target | GLS protein [Homo sapiens] [gi:71051501] | | PubMed | | | Data Table |  |
|
| 31 | [SID24269529] | Inactive | Potency | | qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS [AID602179, Type: confirmatory] | isocitrate dehydrogenase 1 [Homo sapiens] [gi:89573979] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 24269529 | | CID | 15989139 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS | | AID | 602179 | | BioAssay type | confirmatory | | Target | isocitrate dehydrogenase 1 [Homo sapiens] [gi:89573979] | | PubMed | | | Data Table |  |
|
| 32 | [SID24269529] | Inactive | Potency | | qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS [AID602179, Type: confirmatory] | isocitrate dehydrogenase 1 [Homo sapiens] [gi:89573979] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 24269529 | | CID | 15989139 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS | | AID | 602179 | | BioAssay type | confirmatory | | Target | isocitrate dehydrogenase 1 [Homo sapiens] [gi:89573979] | | PubMed | | | Data Table |  |
|
| 33 | [SID24269529] | Inactive | Potency | | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 24269529 | | CID | 15989139 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 34 | [SID24269529] | Inactive | Potency | | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 24269529 | | CID | 15989139 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 35 | [SID24269529] | Inactive | Potency | | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding [AID1460, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 24269529 | | CID | 15989139 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding | | AID | 1460 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 36 | [SID24269529] | Inactive | Potency | | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding [AID1460, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 24269529 | | CID | 15989139 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding | | AID | 1460 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 37 | [SID24269529] | Inactive | Potency | | qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization [AID1468, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 24269529 | | CID | 15989139 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization | | AID | 1468 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 38 | [SID24269529] | Inactive | Potency | | qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization [AID1468, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 24269529 | | CID | 15989139 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization | | AID | 1468 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 39 | [SID24269529] | Inactive | Potency | | qHTS of Nrf2 Activators [AID624171, Type: confirmatory] | Nrf2 [Homo sapiens] [gi:693842] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 24269529 | | CID | 15989139 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of Nrf2 Activators | | AID | 624171 | | BioAssay type | confirmatory | | Target | Nrf2 [Homo sapiens] [gi:693842] | | PubMed | | | Data Table |  |
|
| 40 | [SID24269529] | Inactive | Potency | | qHTS of Nrf2 Activators [AID624171, Type: confirmatory] | Nrf2 [Homo sapiens] [gi:693842] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 24269529 | | CID | 15989139 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of Nrf2 Activators | | AID | 624171 | | BioAssay type | confirmatory | | Target | Nrf2 [Homo sapiens] [gi:693842] | | PubMed | | | Data Table |  |
|
| 41 | [SID24269529] | Inactive | Potency | | qHTS of Nrf2 Activators [AID624171, Type: confirmatory] | Nrf2 [Homo sapiens] [gi:693842] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 24269529 | | CID | 15989139 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of Nrf2 Activators | | AID | 624171 | | BioAssay type | confirmatory | | Target | Nrf2 [Homo sapiens] [gi:693842] | | PubMed | | | Data Table |  |
|
| 42 | [SID24269529] | Inactive | Potency | | qHTS of Nrf2 Activators [AID624171, Type: confirmatory] | Nrf2 [Homo sapiens] [gi:693842] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 24269529 | | CID | 15989139 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of Nrf2 Activators | | AID | 624171 | | BioAssay type | confirmatory | | Target | Nrf2 [Homo sapiens] [gi:693842] | | PubMed | | | Data Table |  |
|
| 43 | [SID24269529] | Inactive | Potency | | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 24269529 | | CID | 15989139 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 44 | [SID24269529] | Inactive | Potency | | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 24269529 | | CID | 15989139 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 45 | [SID24269529] | Inactive | Potency | | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 24269529 | | CID | 15989139 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 46 | [SID24269529] | Inactive | Potency | | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 24269529 | | CID | 15989139 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 47 | [SID24269529] | Inactive | | | IkB Signaling [AID445, Type: confirmatory] | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha [Homo sapiens] [gi:10092619] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 24269529 | | CID | 15989139 | | Outcome | Inactive | | BioAssay | IkB Signaling | | AID | 445 | | BioAssay type | confirmatory | | Target | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha [Homo sapiens] [gi:10092619] | | PubMed | | | Data Table |  |
|
| 48 | [SID24269529] | Inactive | | | IkB Signaling [AID445, Type: confirmatory] | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha [Homo sapiens] [gi:10092619] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 24269529 | | CID | 15989139 | | Outcome | Inactive | | BioAssay | IkB Signaling | | AID | 445 | | BioAssay type | confirmatory | | Target | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha [Homo sapiens] [gi:10092619] | | PubMed | | | Data Table |  |
|
| 49 | [SID24269529] | Inactive | Potency | | A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression [AID624263, Type: confirmatory] | Parkin [Homo sapiens] [gi:3063388] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 24269529 | | CID | 15989139 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression | | AID | 624263 | | BioAssay type | confirmatory | | Target | Parkin [Homo sapiens] [gi:3063388] | | PubMed | | | Data Table |  |
|
| 50 | [SID24269529] | Inactive | Potency | | qHTS Assay to Find Inhibitors of Pin1 [AID504891, Type: confirmatory] | PIN1 gene product [Homo sapiens] [gi:5453898] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 24269529 | | CID | 15989139 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay to Find Inhibitors of Pin1 | | AID | 504891 | | BioAssay type | confirmatory | | Target | PIN1 gene product [Homo sapiens] [gi:5453898] | | PubMed | | | Data Table |  |
|